A B S T R A C T The lysozyme content of human cartilage was measured by incubation of lyophilized, powdered cartilage in a variety of buffers and salt solutions, and the factors controlling the binding of lysozyme within cartilage were studied. Lysozyme was extracted from hyaline cartilage by buffers of pH greater than 9.0, by solutions 1 M in monovalent cations, and by solutions 0.12-0.40 M in divalent cations. The ability of cations to extract lysozyme from cartilage agreed with their known affinities for binding to chondroitin sulfate. The total extractable lysozyme content of five samples of human costal cartilage ranged from 1.45 to 3.36 Ag lysozyme per mg of cartilage; for five samples of hyaline cartilage from peripheral joints the range was 0.80-3.03 Ag lysozyme per mg of cartilage. Cartilage incubated in excess exogenous lysozyme could bind 0.053 equivalents of lysozyme per equivalent of chondroitin sulfate. Fibrocartilage and synovium from knee joints yielded no detectable lysozyme, despite the fact that synovium, a tissue rich in lysosomes, contained measurable quantities of P-glucuronidase. Lysozyme extraction from cartilage was not augmented by incubation with streptolysin S. When incubation was carried out with mild extraction techniques, lysozyme extraction from cartilage tended to parallel uronic acid release, both as a function of time and from one specimen to another. The active material as lysozyme. Lysozyme occurs in human hyaline cartilage as a counterion to polyanionic glycosaminoglycans. Carextracted from cartilage met five criteria for identification tilage lysozyme appears to be extracellular and nonlysosomal. Degradation of cartilage may contribute to the increased serum and synovial fluid lysozyme levels often present in patients with rheumatoid arthritis.
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INTRODUCTION
Lysozyxme is a highly cationic, low molecular weight (14,300) protein which is widely distributed in the human body. Previous reports (1) (2) (3) have documented the common occurrence of elevated levels of serum and/or synovial fluid lysozyme in patients with rheumatoid arthritis. Since lysozyme is present in cellular lysosomes (4) , and since lysosomal rupture is associated with inflammation (5), it has been assumed that the source of the increased lysozyme activity is release of the enzyme from the lysosomes of phagocytic cells.
Fleming, who discovered lysozyme 50 years ago, noted that this enzyme was present in joint tissue (6) . This finding was confirmed by Meyer and Hahnel (7), who noted the "remarkable" lysozyme content of human and guinea pig rib cartilage. Recently, lysozyme has been identified in canine and bovine cartilages (8) , and the effect of lysozyme on the growth of cartilage explants in tissue culture has been studied (9, 10) . The present paper reports quantitative data on the lysozyme content of human cartilage and examines the factors which affect the binding of lysozyme within cartilage and which control release of lysozyme when cartilage is incubated in vitro. Incubation technique. Except as noted otherwise, 20-mg samples of dried powdered tissue were placed in 13 X 100-mm culture tubes to which 1.0 ml of incubation medium was added. The cartilage powder was gently suspended in the medium with a wooden applicator stick to minimize adherence of the powder to the test tube wall. The stoppered tubes were placed in a water bath at 370C and incubated for 24 hr with constant agitation. After centrifugation at 1500 rpm for 5 min, the supernate was aspirated and the residue washed with an additional milliliter of the incubation reagent. The incubation and wash supernates were pooled. Whenever the incubation medium contained a salt concentration greater than 0.2 m, the pooled supernate was dialyzed overnight in the cold against two changes of normal saline. The dialysis tubing was rated by the manufacturer to retain molecules of molecular weight greater than 12,000; in numerous control experiments there was no evidence of lysozyme leakage during dialysis. In order to test the stability of lysozyme in the media used to extract the enzyme from cartilage, control experiments were performed in all cases by incubation of known amounts of lysozyme in salt solutions or buffers identical with those used for cartilage incubation. The control tubes were also dialyzed against normal saline when the salt concentration exceeded 0.2 M. No precipitation of lysozyme was observed in any control tubes, and with the exception of experiments using LiCl at concentrations greater than 0.75 M, there was no loss of lysozyme activity in any control incubation at the salt concentrations or extremes of pH used to extract lysozyme from cartilage.
METHODS
Assay techniques. Lysozyme activity was determined by an automated technique to be described in detail elsewhere (12) . In brief, an automatic sampler was used to add portions of standard lysozyme solution or supernate to a continuously flowing line of substrate (Micrococcus lysodeikticus, 40 mg/100 ml, in 0.066 M phosphate buffer, pH 6.3) which entered a densitometer. The optical density of the substrate was recorded on a strip chart recorder on logarithmic paper. Peaks of decreased optical density were produced on the graph as substrate, acted upon by different amounts of enzyme, entered the flow cell. The decrease in optical density of the substrate was logarithmically related to the lysozyme activity of the sample. Standards for the assay were prepared from purified human lysozyme.' The lysozyme concentration in the cartilage incubation supernates was expressed as micrograms lysozyme released per milligram of powdered cartilage.
Hexuronic acid was measured by the carbazole method (13) . Assay for 8-glucuronidase activity was performed by a standard technique (14) .
Measurement of total extractable lysozyme. The total extractable lysozyme content of the hyaline cartilages was 'Kindly provided by Dr. E. Osserman. determined by exhaustive sequential extraction of a 30 mg portion of each powdered cartilage. The specimens were incubated in 1 ml of 1.0 M NaCl at room temperature for 2 hr, the supernate was aspirated, and fresh reagent was added. This was repeated for a total of five extractions. The five supernates were pooled, dialyzed against normal saline, measured for final volume, and assayed for lysozyme activity. No appreciable amounts of lysozyme could be eluted from cartilage so treated by further washes with the salt solution or by subsequent incubation at 370C for 24 hr in 1.0 M NaCl.
Characterization of cartilage lysozyme. Cartilage supernates rich in lysozyme activity were acidified or alkalinized by addition of equal volumes of 0.2 M acetate buffer, pH 3.7, or universal buffer, pH 10.5 respectively. The samples were placed in a boiling water bath for 90 sec and then retested for lysozyme activity in comparison to a control diluted with normal saline. Similarly, samples of cartilage were heated to boiling in acid or alkaline buffer, washed twice with normal saline, and then subj ected to lysozyme extraction with 1.0 M NaCl (vide infra).
Portions of other supernates were mixed with antiserum to human lysozyme in ratios ranging from 1: 1 to 1: 10 and retested for lysozyme activity.
Incubation supernates and human lysozyme standards were subjected to electrophoresis in 1% agarose in barbital buffer at pH 6.8 (u = 0.038) on 2 X 3 in glass slides for 180 min at a current of 8 ma per slide. After electrophoresis, the slides were overlaid with a suspension of M.
lysodeikticus in 1% agarose in 0.066 M phosphate buffer, pH 6.3, at 450C. After cooling, the slides were incubated overnight in a moist chamber at 250C. The presence of lysozyme on the slide was easily detected as an area of clearing in the previously opaque agarose.
RESULTS
Extraction of lysozyme by variation of pH. When human costal cartilage was incubated in universal buffers, lysozyme was extracted as a function of pH (Fig. 1) . Lysozyme release was constant over the pH range from 2.3 to 8.9 and then increased rapidly over the pH range 9.0 to 10.5. All hyaline cartilage specimens yielded ly- sozyme when incubated in a standardized manner at pH 10.5 . None of these buffers contained sufficient salts to extract lysozymne by cation exchange. In phosphate buffer at identical pH and cation concentration, lysozyme extraction was the same as that seen with universal buffer. However, an interesting finding was that cartilage incubated in tris buffers over the pH range from 8.0 to 10.3, at molarities from 0.001 M to 0.05 M, released no detectable lysozyme, an effect not attributable to instability of lysozyme in such media. Lysozyme extraction in salt solutions. Sodium chloride solutions were effective extractors of caritilage lysozyme (Fig. 2) . Extraction increased rapidly to a maximum at 1.0 M, and then decreased 50% of this value at 3.0 M. All hyaline cartilage specimens yielded lysozyme when incubated in a standardized manner in 1.0 M NaCl. Similar extraction with a maximum at 1.0 M occurred when KCl solutions were used. LiCl also extracted lysozyme from cartilage with a maximum of 0.75 M, but lysozyme was found to lose activity in LiCl solutions of higher molarities. Divalent cations were also potent in the extraction of lysozyme from cartilage. In CaClh solutions (Fig. 3) , ex- traction was maximal at a salt concentration of 0.2 M and no decrease in lysozyme release was noted at concentrations up to 1.5 M. Whereas maximum lysozyme extraction with monovalent cations was attained at strengths of 1 M, divalent cations were effective at xnolarities from 0.12 to 0.40, and yielded more lysozyme than did monovalent cations (Table I) . When the cations K+, Na+, Mg++, Ca't, and Ba' were arranged in order by the lowest molarity at which maximum lysozyme ex- FIGURE 5 Lysozyme extraction and uronic acid release from hyaline cartilage incubated in phosphate buffer. The correlation is statistically significant (P = 0.003).
Relationship of lysozyme extraction to release of f-glucuronidase and uronic acid. When the powdered tissues were incubated in 0.1 M phosphate buffer, u= 0.21, at pH 7.4, all of the hyaline cartilage specimens, but not the synovium, yielded lysozyme. However, the synovial extracts did contain P-glucuronidase activity (approximately 0.2 Fishman U/mg tissue), whereas this lysosomal enzyme was not found in any of the cartilage specimens. Furthermore, when cartilage specimens were incubated with streptolysin S, an agent which ruptures lysosomes (17) , P-glucuronidase activity re-.mained undetectable and lysozyme extraction was not increased. Simultaneous measurement of release of uronic acid and lysozyme extraction for 10 cartilage specimens incubated in phosphate buffer (Fig. 5) revealed that lysozyme release increased as uronate release increased (r = + 0.81).
Characterization of cartilage lysozyme. The active principle extracted from cartilage in these experiments met five criteria for identification as lysozyme. Lysis of the test organism, M. lysodeikticus is a necessary property of the enzyme. The activity of the supernatants was inhibited at salt concentrations greater than 0.2 M (18) . Boiling at alkaline pH resulted in an 80% loss of activity, whereas boiling in acid had no such effect. Similar treatment of powdered cartilage produced the same effect upon the amount of lysozyme which was subsequently extracted from the cartilage. This property of heat stability in acid but not alkaline media is a characteristic of all animal lysozymes (19) . Lysozyme activity in the supernates was sequentially abolished by the incremental addition of goat antiserum to human lysozyme. Finally, both the human lysozyme standards and the active principle in the cartilage extracts had cathodal mobility on electrophoresis at pH 8.6. (8) . It is difficult to compare their results with ours quantitatively, since they used egg white lysozyme as a standard for their assay, which has a different specific activity than the human enzyme (20) , and because they used a diffusion technique for lysozyme measurement, a method which gives different results than that used in the current paper (12) .
DISCUSSION
These authors have also shown that lysozyme can exert profound effects upon the growth of cartilage explants in tissue culture (9, 10) and that some of these effects are shared by protamine, another highly cationic substance. They concluded that lysozyme in these tissues was nonlysosomal and primarily extracellular (21, 22) .
The markedly cationic nature of the lysozyme molecule (iso-electric point = 10.4) suggests that it is bound in cartilage as a counterion to the polyanionic glycosaminoglycans of that tissue. Such binding is known to occur in aqueous solution (16) , where salts can bring about dissociation of the two molecules by interference with ionic binding. Lysozyme extracted from animal cartilage appears to be similarly bound (10) . Titration of the cationic amino groups of the lysozyme molecule by incubation in basic buffers would be expected to dissociate the lysozyme-mucopolysaccharide complex and lead to lysozyme release, as occurred in the present experiments. The shape of the pH elution curve, with a rapid increase above pH 9.0, suggests that lysine, of which there are five residues in human lysozyme (20) , may be a cationic site at which binding occurs. However, the finding of decreased lysozyme extraction from cartilage in NaCl concentrations above 2 M suggests that lysozyme may be capable of other types of binding to cartilage components when its configuration is altered by changes in the ionic environment.
It appears unlikely that diffusion of lysozyme from the bloodstream or from interstitial fluids can account for the lysozyme content of cartilage. The lysozyme content of animal cartilage is greatest in that portion of the tissue farthest from the synovial fluid interface (8) . There is evidence that lysozyme is synthesized in animal cartilage grown in tissue culture (21) . The large, fixed molecules of which cartilage is constructed tend to prevent the entry into the tissue of other large molecules, a phenomenon known as the excluded volume effect (15) . Iron dextran, of molecular weight 7000 (half that of lysozyme) is a molecule that is thus excluded (23) .
Cartilage lysozyme appears to be of nonlysosomal origin. Synovial tissue from patients with rheumatoid arthritis, which is known to be rich in lysosomes (24) contained no lysozyme extractable by our techniques.
Furthermore, P-glucuronidase, a known lysosomal enzyme (5) was detected only in the synovial extracts and not in cartilage. Although it was not anticipated that intact lysosomes would survive the techniques of tissue preparation utilized here, an agent was added to the cartilage which ruptures lysosomes, and there was no demonstrable increase in the amount of lysozyme extracted.
The increased concentration of lysozyme in hyaline cartilage (up to 1000 times greater than that of serum) suggests that cartilage is a potential source of the increased serum and synovial fluid lysozyme levels present in patients with rheumatoid arthritis. Release of glycosaminoglycans during incubation of cartilage paralleled the extraction of lysozyme for 10 different specimens incubated in a buffer at physiologic pH. A similar parallel was noted when cartilage supernates were studied as a function of the time and temperature of incubation. These experiments were performed under mild extraction conditions which resulted in release of only a small fraction of the total cartilage mucopolysaccharide. It should not be inferred that under vigorous extraction conditions with reagents which release much greater quantities of proteoglycan, e.g., 3 M MgCl or 4 M guanidinium chloride, that lysozyme extraction would parallel the release of carbazole-reactive material. Cartilage from patients with rheumatoid arthritis has a decreased glycosaminoglycan content (25) . Lysozyme release from cartilage may accompany the loss of cartilage glycosaminoglycans in diseases such as rheumatoid arthritis.
In addition, we have reported elsewhere (26) studies in which cartilage dissolution was induced in vivo by the injection of papain into rabbits, resulting in the release of chondroitin sulfate into the serum and a twofold rise in serum lysozyme activity. Patients with the arthritis of systemic lupus erythematosus have normal serum lysozyme levels (12) and do not usually manifest destruction of cartilage. The increased serum and synovial fluid lysozyme levels which occur in patients with rheumatoid arthritis are likely to be the result of cartilage degradation as well as lysosomal rupture during inflammation.
